Pricing in this category is mostly hidden, and that is the first thing worth naming. Of the four companies an independent pharmacy is most likely to reach when it searches for DSCSA help, two publish nothing at all. So a page that claims to compare the cost of DSCSA compliance is usually either quoting one vendor or inventing the rest. This page quotes only numbers that were on the vendor’s own site on 31 July 2026, and says plainly where a number does not exist.
Who actually prepares DSCSA documentation for a pharmacy
Three different kinds of company answer that question, and the price shape follows the kind.
- Track-and-trace platforms. InfiniTrak and LSPedia move, host and reconcile serialized transaction data. Neither publishes a price. We compare that category against a written record in detail.
- Compliance programs for pharmacies. PRS Pharmacy Services sells DSCSA360, which bundles the written material and the data feed into one ongoing subscription. It publishes a floor price.
- Documentation preparation. DoseTrace prepares the binder itself and stops there. One fixed fee, no platform.
The two published numbers
PRS Pharmacy Servicesdescribes itself as “Your Trusted Experts in Compliance, Brokerage, Staffing, and Consulting for Independent Pharmacies,” and its DSCSA360 program — “Created by Pharmacists for Pharmacies” — is offered at “as low as $66/month.” For that, its own page lists an “Easy to follow Compliance Guide,” “Required Policies and Procedures/SOPs,” “Required forms,” employee training on the software and SOPs, alerts for suspect data, recalls and expiring trading-partner credentials, EPCIS transaction data from authorized trading partners on one website, and DSCSA audit assistance “available at no cost.”
That is a broader offering than ours, and it would be dishonest to present it otherwise. It covers both halves of the problem — the written record and the ongoing data feed — where DoseTrace covers only the first.
DoseTrace is $499 flat, one time, from a 15-minute intake: the nine-document readiness binder, each document dated. No subscription, no per-store multiplier, no integration, and no data feed.
Recurring versus one-time, with the arithmetic shown
$66/month is PRS’s advertised floor, not a quote — “as low as” is doing work in that sentence, and the real number for a given pharmacy comes from a conversation. But taken at the floor, twelve months is $792, and it recurs: a second year is another $792, a third another. DoseTrace’s $499 is paid once and does not renew.
The comparison people usually want — which is cheaper — has no clean answer, because the two prices do not buy the same thing. The comparison that is actually decidable is this: is your gap a one-time gap or a continuing one? A missing set of SOPs, a missing exemption determination and a missing training attestation are one-time gaps. They get written once and maintained. A wholesaler data feed that has to keep arriving, keep being monitored for suspect product and keep flagging recalls is a continuing service, and a continuing service is correctly priced as a subscription. Paying a subscription for a one-time gap means paying for the same finished documents every month. Paying a one-time fee for a continuing need leaves the continuing need unmet.
What neither number includes
Nothing on this page is the cost of the compliance itself — the staff hour spent scanning an incoming order, the pharmacist time reading a suspect-product alert, the wholesaler portal you already pay for inside your primary contract. Those sit underneath every option here and do not disappear with any of them.
The expensive mistake is upstream of the price
Before comparing any of these numbers, confirm which exemption track you are on, because it changes what you are buying and when. The FDA’s small-business-dispenser exemption runs until 27 November 2026, and it reaches a pharmacy only if the corporate entity that owns it had 25 or fewer full-time pharmacists and qualified technicians — counted across the whole company, not per store, and counted as of 27 November 2024, not today. PRS’s own page points at the same instrument, describing “the exemption announced on 6/12/2024.”
If your company was over that line, the relief you may believe runs to November 2026 ran only to November 2025 and has already lapsed. That is the misreading that turns a planned purchase into an urgent one — what the exemption never covered walks through it, and what actually changes on 27 November 2026 takes the six obligations one at a time.
Choosing without a demo
- You cannot reach your transaction data without phoning a wholesaler. That is a continuing gap. A platform or a program with a data feed is the right purchase.
- Your data arrives fine, but an inspector asking for a dated SOP today would get nothing. That is a one-time gap, and a fixed-fee binder closes it.
- Both are true. Then both are worth buying, and the order matters less than starting before the date rather than after it.
Check which exemption track you are on, free — about a minute, and it stores nothing. Contact reaches a person.
The 27 November 2026 expiry and the 25-employee threshold are quoted from the FDA document DSCSA Exemptions from Certain Requirements Under Section 582 of the FD&C Act for Small Business Dispensers, issued 12 July 2024, retrieved and verified 31 July 2026. PRS Pharmacy Services pricing and program contents are quoted from prsrx.com/compliance/dscsa360 as retrieved on 31 July 2026; the absence of published pricing at infinitrak.us and lspedia.com was checked on the same date. All three are independent companies with no relationship to DoseTrace, and their own sites are the authority on their own products and prices — if a number here disagrees with theirs, theirs is correct and we want to know. DoseTrace is not a law firm and nothing here is legal advice.